Female pattern hair loss looks different from the male version, and so does the treatment list. Women rarely go bald at the crown the way men do. Instead the part widens, the hair over the top of the scalp thins, and the density drops while the frontal hairline usually holds. The drugs that help are also a different set, and one of the most common male treatments, finasteride, is restricted for women who could become pregnant. This post walks through what actually works for women and why the options are what they are.

First, Confirm It Is Pattern Loss

Female pattern hair loss (also called female androgenetic alopecia) is gradual, patterned thinning driven by genetically susceptible follicles miniaturizing over time. Before treating it as that, it is worth ruling out the mimics, because women have several common reversible causes of thinning that no pattern-loss drug will fix.

The big ones to check are thyroid disease, iron deficiency (ferritin in particular), and telogen effluvium, the diffuse shedding that follows an illness, a birth, a crash diet or major stress. A hormonal cause such as polycystic ovary syndrome is worth considering in a woman with irregular periods, acne, or excess body hair. A basic workup, thyroid function and iron studies, sorts many cases and sometimes makes drug treatment unnecessary. Treating the underlying problem lets the hair recover on its own.

Option 1: Minoxidil, the First-Line Choice

Minoxidil is the first-line, FDA-approved treatment for female pattern hair loss, and it is where most women start. It works by prolonging the growth phase of the hair cycle and improving blood flow to the follicle. It comes in two forms.

Topical minoxidil

The 2 percent solution and the 5 percent foam are both used in women. The 5 percent foam once daily is a common regimen and avoids some of the scalp irritation of the liquid. It is available without a prescription. The main downsides are the need to keep using it (the benefit fades if you stop), scalp irritation in some users and unwanted facial hair if the product migrates off the scalp. Results take three to six months to judge.

Low-dose oral minoxidil

Increasingly, clinicians use low-dose oral minoxidil for women, often starting at 0.625 to 1.25 mg daily, when the topical is not tolerated, not working, or simply not being kept up. The randomized evidence through 2024 supports it for female pattern hair loss. The tradeoff is systemic side effects, with unwanted body and facial hair being the leading reason women stop, plus the cardiovascular profile of a vasodilator, which is why it is prescribed and monitored rather than bought off the shelf.

Option 2: Spironolactone, the Antiandrogen

Spironolactone is the other workhorse for female pattern hair loss, used off-label and often alongside minoxidil. It started life as a blood pressure and fluid drug, but it also blocks the androgen receptor and dampens androgen production. By reducing the androgenic drive on the follicle, it can slow the thinning that DHT-sensitive hairs undergo.

The evidence for hair loss is mostly observational rather than from large randomized trials, but it is supportive, and spironolactone has a long track record in dermatology for hormonal hair and skin problems in women. It is typically dosed at 50 to 100 mg daily, sometimes higher, and the hair effect is judged at six to twelve months. It is frequently combined with minoxidil because the two work through different mechanisms.

The things to know before starting spironolactone:

  • Pregnancy must be avoided. Spironolactone can feminize a male fetus, so reliable contraception is required, and it is contraindicated in pregnancy.
  • Potassium matters. Because it is potassium-sparing, it can raise potassium, especially with kidney disease, older age, or interacting drugs like ACE inhibitors and ARBs. Baseline potassium and kidney function are checked when risk factors are present.
  • Common side effects include menstrual irregularity, breast tenderness, increased urination and lightheadedness.

It is often paired with a combined oral contraceptive, which provides contraception and can add its own antiandrogen benefit.

Why Finasteride Is Restricted Before Menopause

Here is the question many women ask: if finasteride blocks DHT and DHT drives pattern loss, why is it not just prescribed to women too? The answer is a hard safety line. Finasteride and dutasteride can cause hypospadias, a serious genital malformation, in a developing male fetus. That is why these drugs carry an absolute contraindication in women who are or may become pregnant, and why pregnant women are told not even to handle broken or crushed tablets.

For that reason, finasteride is generally not used in premenopausal women who could become pregnant. When it is used in women at all, it is in postmenopausal women, or with stringent contraception and full counseling, and even then the evidence for benefit in women is mixed and weaker than the male data. The practical result is that for most premenopausal women, the realistic options are minoxidil and spironolactone, not finasteride. The restriction is about fetal risk, not about whether the drug could theoretically help.

Putting It Together

For a premenopausal woman with confirmed pattern hair loss, a common plan is to start with minoxidil, topical or low-dose oral, and add spironolactone with reliable contraception if more effect is needed or if there are hormonal features. After menopause, finasteride becomes a possible addition because the pregnancy concern no longer applies, though it remains off-label for women and the response is variable.

Two adjuncts worth mentioning. Ketoconazole shampoo is a low-risk add-on with mild antiandrogen and anti-inflammatory scalp effects. Procedure-based options like platelet-rich plasma and low-level laser devices exist with more modest and variable evidence. The medication backbone for most women remains minoxidil and spironolactone.

The Bottom Line

Female pattern hair loss has real, evidence-backed treatments, but the list is not the same as the male one. Minoxidil is first-line and the place to start. Spironolactone is the antiandrogen workhorse, used off-label and often combined with minoxidil, with a firm requirement to avoid pregnancy. Finasteride is restricted before menopause because of fetal risk, which is why it is not the default for women the way it is for men. Rule out thyroid, iron and shedding first, then build from minoxidil up with a clinician who can match the plan to your hormones and your history.

Reviewed By

[Reviewed by: clinician name, credential. Last reviewed: date.]

Ready to find the right plan for your hair? Start an intake and a licensed clinician will rule out the reversible causes and recommend a treatment that fits your history.

This article is for education and is not a substitute for individual medical advice from your own clinician.